The fallout of a forensic audit: Medikabazaar founders set to lose stock options
The company’s board is contemplating cancelling the management stock options that were due to the founders at the end of June, expecting Medikabazaar to not meet its revenue and operational earnings targets for 2023-24, according to three people familiar with the deliberations. The medical-technology company had to correct its revenue for 2023-24 after a forensic